[EN] ADAMANTANYL-SUBSTITUTED BENZAMIDE COMPOUNDS AND THEIR USE AS P2X7 RECEPTOR ANTAGONISTS<br/>[FR] COMPOSÉS BENZAMIDE SUBSTITUÉS PAR ADAMANTANYLE ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DU RÉCEPTEUR P2X7
申请人:UNIV SYDNEY
公开号:WO2020037350A1
公开(公告)日:2020-02-27
The present invention relates to adamantanyl-substituted benzamide compounds and their use as antagonists of the P2X7 purinoreceptor. The invention further relates to methods for the treatment of disease and conditions associated with the P2X7 purinoreceptor.
ADAMANTANYL-SUBSTITUTED BENZAMIDE COMPOUNDS AND THEIR USE AS P2X7 RECEPTOR ANTAGONISTS
申请人:The University of Sydney
公开号:US20210323910A1
公开(公告)日:2021-10-21
The present invention relates to adamantanyl-substituted benzamide compounds and their use as antagonists of the P2X
7
purinoreceptor. The invention further relates to methods for the treatment of disease and conditions associated with the P2X
7
purinoreceptor.
Solvolysis of 1-substituted-2-adamantyl sulfonates. Bridging or no bridging?
作者:D. Farcasiu
DOI:10.1021/ja00433a041
日期:1976.8
Preparations of some 1,2- and 1,4-disubstituted adamantanes